Aditxt, Inc. - Common Stock (ADTX)
4.3700
+4.3500 (21750.00%)
Aditxt Inc is a biotech company focused on enhancing the immune system through innovative technologies designed to promote immune tolerance
The company seeks to develop therapies that can help manage and treat immune-related diseases by leveraging its proprietary platform to create customized solutions. Aditxt's research and development efforts aim to address a range of immunological disorders, potentially transforming the landscape of immunotherapy and improving patient outcomes through better immune system management.
Previous Close | 0.0200 |
---|---|
Open | 5.100 |
Bid | 4.490 |
Ask | 4.730 |
Day's Range | 4.110 - 5.302 |
52 Week Range | 0.0200 - 218.00 |
Volume | 592,670 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 178,375,183 |
News & Press Releases

Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session.
Via Chartmill · March 17, 2025

Intrigued by the market activity in the middle of the day on Monday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · March 17, 2025

Via Benzinga · March 17, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · March 17, 2025

Aditxt (NASDAQADTX), a health innovation platform, provided a corporate update highlighting progress across its subsidiaries and acquisition initiatives. The company remains focused on advancing its autoimmune treatment subsidiary Adimune , precision diagnostics unit Pearsanta , and neurological monitoring subsidiary Adivue , while also pursuing strategic acquisitions, including Appili Therapeutics and Evofem Biosciences. Additionally, Aditxt will launch its Aditxt Weekly Update series on March 21, 2025, featuring CEO Amro Albanna and Evofem CEO Saundra Pelletier, aiming to enhance transparency and investor engagement.
Via Investor Brand Network · March 17, 2025

The US market session of Monday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · March 17, 2025

Aditxt, Inc. (NASDAQADTX) ("Aditxt" or the "Company"), an innovation platform dedicated to discovering, developing, and deploying promising health innovations, today provided a corporate update outlining recent achievements and strategic milestones across its subsidiaries and strategic acquisition initiatives. In addition, the Company will be launching Aditxt Weekly Updates, starting Friday March 21, 2025, and continuing throughout the second quarter of 2025.
By Aditxt, Inc. · Via Business Wire · March 17, 2025

As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · March 14, 2025

Stay up-to-date with the latest market trends one hour before the close of the markets on Friday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · March 14, 2025

Friday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity!
Via Chartmill · March 14, 2025

Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · March 14, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday.
Via Chartmill · March 14, 2025

Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · March 13, 2025

Discover the most active stocks in Thursday's session. Stay informed about the stocks that are generating the most trading volume!
Via Chartmill · March 13, 2025

Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · March 13, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Thursday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · March 13, 2025

Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.
Via Chartmill · March 13, 2025

Via Benzinga · March 13, 2025

U.S. stock futures fell again on Thursday after a brief respite on Wednesday, following a softer-than-expected inflation print.
Via Benzinga · March 13, 2025

Via Benzinga · March 13, 2025

Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.
Via Chartmill · March 12, 2025

Via Benzinga · March 12, 2025

Aditxt, Inc. (NASDAQADTX) (“Aditxt” or the “Company”), an innovation platform dedicated to discovering, developing, and deploying promising health innovations, announced today that it will effect a 1-for-250 reverse split of its common stock. Commencing with the opening of trading on the Nasdaq Capital Market on March 17, 2025, the Company’s common stock will trade on a post-split basis under the same symbol ADTX. The reverse stock split was approved by the Company’s stockholders at the special meeting held on February 28, 2025, with the final ratio determined by the Company’s board of directors.
By Aditxt, Inc. · Via Business Wire · March 12, 2025

As market volatility continues, small-cap stocks are attracting investor attention with groundbreaking technological advancements, biotech breakthroughs, and resource expansion projects . Companies across multiple industries are making major strides, positioning themselves for growth and long-term value creation . Here are some of the most compelling penny stocks that are making headlines
Via AB Newswire · March 10, 2025